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Background: Acute rejection remains one the most serious problems in lung trans-
plantation. Although biopsy has been used for assessing the dysfunction of grafts, it
is difficult to determine rejection at an early stage. Lymphocyte infiltration and
activation play an important role in acute rejection of transplanted organs, and the
dynamic change of lymphocyte subpopulations might be a marker to determine graft
rejection after lung transplantation.
Methods: A rat lung transplant model was used. Graft-infiltrating lymphocytes in
lung tissues were examined by means of histology, and isolated cells were analyzed
by means of flow cytometry. Phenotypes of lymphocytes in the regional and remote
lymph nodes, spleen, peripheral blood, and bronchoalveolar lavage fluid were also
measured by means of flow cytometry.
Results: After allograft transplantation, increased lymphocytes were seen in allo-
grafts but not in isografts. In allografts the percentage of T cells increased from day
1 to day 5, whereas that of B cells was decreased. The CD4/CD8 ratio decreased
in allografts. The proportion of CD4/CD45RC cells increased in the allografts,
which was mainly due to the increase of CD45RC cells in the total CD4 cells.
Similar changes were found in regional mediastinal lymph nodes but not in the
mesenteric lymph nodes, spleen, or peripheral blood. Thus this is a specific response
to lung allografts. Importantly, CD45RC cells were significantly increased in the
bronchoalveolar lavage fluid.
Conclusion: Significant change of lymphocyte subpopulations is a sign of lympho-
cyte activation. Increased CD4/CD45RC cells in lung allografts could be an early
marker of acute rejection, which can be examined by means of lung lavage and flow
cytometry.
Lung transplantation is an effective clinical option for end-stage lungdiseases. However, the incidence of acute rejection is higher afterlung transplantation than after other solid organ transplantations.1Five percent of deaths during the first 30 days after lung transplan-tation are directly caused by acute rejection.2 Although biopsy hasbeen used for assessing the dysfunction of the grafts, it is difficult to
determine the rejection at the early stage.
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Lymphocyte infiltration and activation play an important
role in acute rejection of transplanted grafts. We have pre-
viously demonstrated that in a rat lung transplantation
model lymphocyte infiltration had a latent phase on day 1,
a vascular phase on day 3, and an alveolar phase on day 5,
with the maximal infiltration on day 5 after transplanta-
tion.3,4 To determine whether the increased lymphocyte
infiltration in lung grafts is associated with changes of
subpopulations, in the present study we examined the ex-
pression of T cells, B cells, and CD4/CD8 ratio. We
focused on the expression of a subset of CD45 markers in
CD4 cells.
CD45 is a transmembrane molecule expressed by all
nucleated hematopoietic cells and their precursors.5 A long
intracytoplasmic tail of CD45 possesses 2 protein tyrosine
phosphatase domains. It has been suggested that CD45 is a
drug target and central regulator involved in differentiation
of multiple hematopoietic cell lineages, autoimmunity, and
antiviral immunity.6 CD45 is expressed in several isoforms
generated by means of alternative mRNA splicing of vari-
able CD45 exons. By using specific monoclonal antibodies
(mAbs), restricted regions have been identified from CD45
isoforms. They are expressed as CD45R, followed by a
letter to indicate the specific region where the mAbs bind.
For example, in rats the MRC-OX22 mAb binds to
CD45RC. CD45 isoforms are divided into CD45Rhigh
(high-molecular-weight isoforms, 220-190 kd) and
CD45Rlow (low-molecular-weight isoforms, 180 kd). The
CD45Rlow cells are detected in human subjects on the basis
of antibodies to CD45RO, such as UCHL-1. The CD45Rlow
cells in mice and rats are identified by a lack of staining with
the antibodies for CD45RB and CD45RC, respectively.7
CD4 T cells can be divided into subpopulations on the
basis of the status of their CD45RC expression. These
subpopulations of CD4 cells have different functions. By
means of mitogenic stimulation, CD4/CD45RC cells
produced interleukin 2 and interferon  and showed little
expression of interleukin 4 mRNA, whereas CD4/
CD45RC cells showed the opposite result.8 The shift from
CD45Rhigh (CD45RA/B/C) to CD45Rlow (CD45RO) in
human subjects, from CD45RB to CD45RB in mice, and
from CD45RC to CD45RC in rats has been observed
under different conditions, including immunologic memory
and activation.9-12 In human subjects several reports have
shown that after solid organ transplantation (kidney, heart,
and liver), the severity of rejection is significantly associ-
ated with the change of infiltrating T cells from those
expressing CD45high molecules (CD45RA) toward those
expressing CD45Rlow molecules (CD45RO).13-16 However,
in most of these studies CD45Rhigh or CD45Rlow cells are
not double stained with CD4 marker.
The changes of CD45R isoforms in lung allografts are
especially unclear; the subpopulations of CD4 cells in lung
allografts according to their expression of CD45R markers
have not been well studied. In the present study, using a rat
lung transplantation model, we investigated the expression
of CD45RC in CD4 T cells in the grafts and in the
recipients (the regional and nonregional lymph nodes of the
lung, the spleen, and the peripheral blood) with the progress
of acute graft rejection. In addition, bronchoalveolar lavage
fluid (BALF) collected from allografts was analyzed to
determine whether the changes in the grafted lung tissues
could be examined from the BALF. Our results showed that
CD4/CD45RC cells in the lung allografts could be an
indicator for the advance of acute rejection.
Materials and Methods
Animals
Inbred male rats of the LEW (RTl1) and BN (RTln) strains were
obtained from Charles River (Kanagawa, Japan). Rats from 12 to
16 weeks old were used in all experiments. Animals were housed
in pathogen-free conditions and received humane care in compli-
ance with the “Guide for the Care and Use of Laboratory Animals”
prepared by the Institute of Laboratory Animal Resources, Na-
tional Research Council, and published by the National Academy
Press, revised 1996, and institutional guidelines.
Transplantation
Left lungs from BN or LEW donors were orthotopically trans-
planted to LEW recipients according to the modified technique of
Prop and colleagues.17 Briefly, the recipient rat was anesthetized
with oxygen, nitrous oxide, and halothane (4%) and intubated. The
recipient rat was artificially ventilated at a rate of 90 breaths/min
and a tidal volume of 7 mL/kg with oxygen, nitrous oxide, and
halothane (1.5%). After a left-side thoracotomy, the native left
lung and the postcaval lobe of the right lung were dissected. The
donor rat was given pentobarbital (50 mg/kg) intraperitoneally and
ventilated at a rate of 90 breaths/min and a tidal volume of 7
mL/kg. A donor left lung was resected after flushing through the
pulmonary artery with cold normal saline. The donor lung was
implanted into the recipient’s chest. By using an operating micro-
scope, the pulmonary vein and artery were anastomosed with a
continuous suture (10-0 nylon, Dermalon; American Cyanamid
Co, Danbury, Conn). The bronchial anastomosis was performed
with an interrupted suture (10-0 nylon). After the initiation of
ventilation and reperfusion, the thorax was closed, leaving a chest
drainage tube. This tube was removed after the recipient rat re-
covered from anesthesia.18
Preparation of Lymphocytes from Grafts, Spleen,
Lymph Nodes, and Peripheral Blood in Recipient Rats
Recipient rats were killed on days 1, 3, or 5 after the operation. The
rats were given pentobarbital (50 mg/kg administered intraperito-
neally) and ventilated artificially. One milliliter of peripheral blood
was obtained by means of tail vein puncture with heparinized
syringes. After laparotomy, the spleen was removed and saved in
cold phosphate-buffered saline (PBS). After thoracotomy, the left
atrium was incised to wash out blood in pulmonary vessels, and the
grafted lung was irrigated with 100 mL of cold saline solution
administered through the pulmonary arterial trunk with 20 cm H2O
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pressure. The heart and lungs were excised, and the left lung was
removed. The mediastinal lymph nodes, which were the regional
lymph nodes in the chest, and the mesenteric lymph nodes, which
were the nonregional lymph nodes, were collected separately. The
mediastinal lymph nodes in this study included the parathymic and
the posterior mediastinal lymph nodes, which drain the thoracic
viscera of the rat.19
Cells were segregated from lungs according to a method de-
scribed by Holt and associates.20 The lungs were agitated in a
complete medium (RPMI 1640 with 10% fetal bovine serum
[FBS] and 105 mol/L 2-mercaptoethanol) containing 10 mg/mL
collagenase and 1 mg/mL DNase. To each sample was added 10
mL of RPMI 1640 medium, and the mixture was then incubated at
37°C for 90 minutes. Then cells were filtered through cotton and
washed with RPMI 1640 medium twice. Cells were adjusted to a
final concentration of 1.0 107/mL with the RPMI 1640 medium.
Lymphocytes of the grafted lungs were separated with Lympho-
cyte-Rat (Cedarlane, Ontario, Canada) as a density separation
medium by means of centrifugation (20 minutes, 400g, room
temperature) and then washed 2 times with the medium. Cells were
adjusted to the proper concentration in PBS containing 2% FBS
and 0.02% sodium azide for phenotype analysis by means of flow
cytometry.
Single-cell suspensions from the lymph nodes or spleen were
prepared by teasing tissue through a nylon mesh screen, and then
the cells were collected in PBS containing 2% FBS and 0.02%
sodium azide. The red blood cells were lysed with Tris–ammo-
nium chloride. The cells were adjusted to the proper concentration
in PBS containing 2% FBS and 0.02% sodium azide for flow
cytometry.
Bronchoalveolar Lavage for Allografted Lungs
Bronchoalveolar lavage was performed for a number of the al-
lografted lungs. Two milliliters of BALF was recovered from each
graft. An 18-gauge needle with its point removed was inserted into
the left main bronchus of a graft, and it was then bound with
thread. Cold PBS (0.5 mL) was injected into the bronchus each
time until 2.0 mL of BALF was recovered.
Antibodies
Fluorescein isothiocyanate (FITC)–conjugated OX-22 (anti-
CD45RC), FITC-conjugated OX-19 (anti-CD5), and FITC-conju-
gated OX-33 (anti-B cell) mAbs were purchased from Serotec
(Oxford, United Kingdom). Biotin-conjugated W3/25 (anti-CD4)
and FITC-conjugated OX-8 (anti-CD8) mAbs were kindly pro-
vided by Dr K. Himeno (Tokushima, Japan).
Flow Cytometry
For 2-color flow cytometry, cells from each sample were stained
for 30 minutes with optimal dilutions of antibodies: biotin-conju-
gated W3/25 (anti-CD4) and FITC-conjugated OX-8 (anti-CD8) or
biotin-conjugated W3/25 and FITC-conjugated OX-22 (anti-
CD45RC). Each sample was incubated with avidin-phycoerythrin
for 30 minutes. For single-color flow cytometry, cells from each
sample were stained for 30 minutes with optimal dilutions of
antibodies: FITC-conjugated OX-19 (anti-CD5) and FITC-conju-
gated OX-33 (anti-B cell). The labeled cells were analyzed with a
FACScan (Becton-Dickinson, Mountain View, Calif). PBS con-
taining 2% FBS and 0.02% sodium azide was used for all flow
cytometric analyses. Dead cells and nonlymphoid cells were ex-
cluded from analysis by means of selective gating on the basis of
anterior and right-angle scatter.
Graft-infiltrating Cells
The lymphoid cells isolated from the grafted lungs were analyzed
by means of flow cytometry. The lymphocytes that were morpho-
logically separated by means of anterior and right-angle scatter
measurements were defined as graft-infiltrating lymphocytes
(GILs). The accuracy of this separation was confirmed by means of
double staining with biotin-conjugated W3/25 (anti-CD4) and
FITC-conjugated OX-8 (anti-CD8) mAbs.
Statistics
All data are expressed as means  SD. Data were analyzed by
using the Bartlett test and 1-way analysis of variance, followed by
the Scheffe method for multiple comparisons among groups. For
comparison between isografts and allografts, the unpaired Student
t test was applied.
Results
Lymphocyte Infiltration in Allograft Lungs
In the allografts peribronchial and perivascular edema was
observed on day 1 after transplantation. On day 3, perivas-
cular lymphocyte infiltration, predominantly in the periph-
eral pulmonary vein, was found. On day 5, lymphocytes
formed peribronchial and perivascular cuffing and infil-
trated into the interstitium, which was associated with dis-
tortion of lung structure (Figure 1). In contrast, although
peribronchial and perivascular edema was observed on days
3 and 5 after transplantation, lymphocyte infiltrations were
not seen in isografts (Figure 1).
Changes of GIL Profiles in Allografts
In the normal rat lung the number of lymphocytes in the
lung is very low and difficult to analyze (data not shown). In
isografts lymphocytes in the lung were mainly T cells (53%
and 57% on days 3 and 5, respectively). B cells were about
20% of total infiltrating cells (Table 1). In the allografts the
proportion of T cells, expressed as CD5 cells, increased
from 33% to 54% from day 1 to day 5 after transplantation.
Meanwhile, B cells decreased from 41% to 30% (P  .05,
Table 1).
The expression of CD4 and CD8 cells in isografts was
relatively stable from day 3 to day 5. In allografts, although
CD4 cells increased from 35% to 45% from day 1 to day
5, the increase of CD8 cells was from 7% to 17%. There-
fore the CD4/CD8 ratio decreased from 5.2% to 2.8%
(P  .05, Table 1). The expression of T cells (CD5 cells)
also increased in allografts but remained constant in the
isografts. Taken together, in the allografts not only did the
lymphocyte infiltration significantly increase but also the
subpopulations of lymphocytes changed in a time-depen-
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dent manner. These phenomena are allograft specific be-
cause they are not seen in isografts.
Proportion of CD4/CD45RC Cells Increased During
Acute Rejection
We then analyzed the expression of CD45RC in the GILs by
means of dual staining of cells, followed by flow cytometry.
Representative results are shown in Figure 2. The propor-
tion of CD4/CD45RC cells to GILs increased from 20%
to 38% during the process of acute rejection in allografts
(from day 1 to day 5) but not in the isografts between day
3 and day 5 after lung transplantation (Figure 3, A). The
proportion of CD4/CD45RC cells to GILs in allografts
was also significantly higher than that in isografts on both
days 3 and 5 (Figure 3, A).
Considering that the proportion of CD4 cells in GILs
also increased during the progress of acute rejection (Table
1), we then focused on the proportion of CD4/CD45RC
cells in the CD4 cell population. The proportion of CD4/
CD45RC cells to CD4 cells in GILs increased with the
advance of acute rejection and significantly increased from
57% on day 1 to 86% on day 5 (P  .01; Figure 3, B) after
allotransplantation. In the isografted lungs the proportion of
CD4/CD45RC cells to CD4 cells in GILs did not
change between days 3 and 5 (Figure 3, B). The proportion
of CD4/CD45RC in CD4 cells on days 3 and 5 in
allografts was significantly higher than that in isografts on
days 3 and 5, respectively. Therefore during allograft rejec-
tion, the increased CD4 cells contain more CD45RC
cells.
Changes of CD4/CD45RC Cells in Other
Lymphocytic Tissues
We also analyzed the proportion of CD4/CD45RC cells
to total lymphocytes and the proportion of CD4/
CD45RC cells to CD4 cells in mediastinal and mesen-
Figure 1. Lymphocyte infiltration in allograft lungs. A time-dependent increase in lymphocytes was seen in
allografts from day 1 to day 5 after transplantation, which was not seen in isografts on days 3 and 5. (Hematoxylin
and eosin staining; original magnification 40.)












T cells (CD5), % 33.6 3.3 47.9 2.8 54.1 5.6* 52.5 3.7 56.9 7.0
B cells, % 41.5 4.7 21.5 5.6† 30.0 6.5* 24.3 2.3 21.9 4.1
CD4, % 35.5 4.5 44.3 6.8 44.7 5.3‡ 49.2 4.9 54.0 0.3
CD8, % 7.0 1.5 12.7 4.5 16.8 4.4* 12.0 2.9 18.4 3.4
CD4/CD8 ratio 5.2 1.4 3.8 0.9 2.8 0.7* 4.3 1.1 3.0 0.5
*P  .05 compared with day 1 by using Scheffe method.
†P  .01 compared with day 1 by using Scheffe method.
‡P  .05 compared with isografts on day 5 by using unpaired Student t test.
General Thoracic Surgery Takehisa et al
678 The Journal of Thoracic and Cardiovascular Surgery ● October 2002
G
TS
teric lymph nodes, spleen, and peripheral blood lympho-
cytes (PBLs). In the mediastinal lymph nodes of the
recipient rats, the proportion of CD4/CD45RC cells to
total lymphoid cells on day 5 was significantly increased
over that on day 3 after allograft lung transplantation (Table
2). The proportion of CD4/CD45RC cells to CD4 cells
Figure 2. Representative results of the FACS analysis in the allografts (on days 1, 3, and 5) and in the isografts (on
days 3 and 5) after lung transplantation. Top, Two-dimensional dot-plotting graphs show the results of the
3-parameter analysis by CD4 (biotin-conjugated W3/25 and avidin-phycoerythrin) and CD45RC (FITC-conjugated
OX-22) staining for GILs. Bottom, Histograms show percentages of CD45RC and CD45RC cells in CD4 cells.
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in mediastinal lymph nodes on day 5 was also significantly
increased compared with that on days 3 and 1 in allografts
(Table 3). In the mesenteric lymph nodes, spleen, and PBLs,
there were no significant changes in the proportion of
CD4/CD45RC cells to lymphoid cells and in the propor-
tion of CD4/CD45RC cells to CD4 cells during the
progress of the acute rejection after allograft transplantation.
Thus the changes in lymphocyte subsets in the allografts
were restricted to the regional lymph nodes.
In the isograft recipients neither the proportion of CD4/
CD45RC cells to lymphoid cells nor the proportion of
CD4/CD45RC cells to CD4 cells changed in mediasti-
nal lymph nodes, mesenteric lymph nodes, and the spleen.
Interestingly, the ratio of CD4/CD45RC cells to lym-
phoid cells and the ratio of CD4/CD45RC cells to CD4
cells increased in PBLs 5 days after lung transplantation
compared with that after 3 days (Tables 2 and 3).
Increase of CD4/CD45RC Cells in BALF After
Allograft Transplantation
We then examined the CD4/CD45RC expression profile
in the BALF to determine whether the changes in lympho-
cyte subpopulations could be measured through lavage.
Representative results are shown in Figure 4. The dot counts
on days 1 and 3 are lower than that on day 5 because there
were fewer lymphocytes in the BALF on days 1 and 3.
Although the proportion of CD4/CD45RC cells to lym-
phocytes in the BALF gradually increased with the advance
of acute rejection in allografts, statistical analysis was not
able to reach a significant difference (Figure 5, A). On day
1, about half the CD4 cells in the BALF were CD45RC
cells. The proportion of CD4/CD45RC cells to CD4
cells significantly increased on days 3 and 5 compared with
that on day 1, and almost all CD4 cells became CD45RC
Figure 3. Significant increase of CD4/CD45RC cells in the lung allografts. A, The proportion of CD4/CD45RC
cells to GILs was increased during the progress of acute rejection in allografts. *P < .05 compared with that on
days 1 and 3 in allografts by using the Scheffe method. #P < .05 compared with isografts by using the Student t
test. B, Proportion of CD4/CD45RC cells to CD4 cells in GILs was increased during acute rejection in allografts.
*P < .01 compared with that on days 1 and 3 in allografts by using the Scheffe method; #P <.05 and ##P < .01
compared with isografts by using the Student t test.
TABLE 2. Proportion of CD4/CD45RC cells in lympho-




LN (%) Spleen (%) PBL (%)
Allograft
Day 1 (n  3) 12.5 1.2 15.9 0.6 19.2 1.2 13.4 1.8
Day 3 (n  7) 8.5 2.5 16.5 5.1 16.3 3.8 18.9 4.3
Day 5 (n  6) 15.8 3.8* 20.6 3.3 20.6 6.1 18.5 2.7
Isograft
Day 1 (ND) — — — —
Day 3 (n  7) 10.1 0.5 16.0 1.0 18.3 3.7 16.6 1.3
Day 5 (n  6) 11.5 2.6 18.1 3.5 16.7 2.9 19.8 1.9†
ND, Not done.
*P  .01 compared with day 3 in allografts by using Scheffe method.
†P  .05 compared with day 3 in isografts by using Scheffe method.
TABLE 3. Proportion of CD45RC cells in CD4 cells in




LN (%) Spleen (%) PBL (%)
Allograft
Day 1 (n  3) 29.2 4.8 30.6 1.7 42.9 2.5 31.4 1.2
Day 3 (n  7) 31.6 4.6 34.2 6.2 38.3 4.8 33.0 5.8
Day 5 (n  6) 43.9 8.5* 40.8 5.5 45.8 7.6 35.9 5.7
Isograft
Day 1 (ND) — — — —
Day 3 (n  7) 31.8 3.1 33.7 3.1 37.0 5.3 28.2 2.7
Day 5 (n  6) 33.7 5.7 35.7 5.5 36.5 5.2 34.7 1.3†
ND, Not done.
*P  .05 compared with days 1 and 3 in allografts by using Scheffe
method.
†P  .05 compared with day 3 in isografts by using Scheffe method.
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cells (Figure 5, B). Almost all CD4 cells in the BALF were
CD45RC cells on days 3 and 5 in allografts. The ratio of
CD4/CD45RC cells to CD4 cells might be a very
sensitive indicator of acute rejection of lung grafts.
Discussion
We have previously demonstrated that the maximal increase
of GILs during the progress of acute rejection in lung
allografts was on day 5 after transplantation,3,4 and the
Figure 4. Representative results of the FACS analysis in the BALF recovered from the allografts. Two-dimensional
dot-plotted graphs show the results of the 2-parameter analysis by CD4 and CD45RC for the lymphocytes in the
BALF. Histograms show the results of the percentage of CD4/CD45RC cells in total CD4 cells.
Figure 5. CD4/CD45RC cells increased in the BALF collected from the allografted lungs. A, Proportion of
CD4/CD45RC cells was increased in allografts. B, Proportion of CD4/CD45RC cells to CD4 cells significantly
increased in the BALF recovered from the allografted lungs. On day 3, most of the CD4 cells in the BALF were
CD45RC cells. *P < .01 versus day 1 by using the Scheffe method.
Takehisa et al General Thoracic Surgery
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 4 681
G
TS
lymphocyte infiltration showed a latent phase on day 1, a
vascular phase on day 3, and an alveolar phase on day 5 on
the basis of morphologic criteria described by Prop and
coworkers.21 Similar results were seen in the present study
(Figure 1). In this study we showed that the subpopulations
of lymphocytes also significantly changed after allograft
transplantation, with an increasing percentage of T cells and
a decreasing percentage of B cells. The CD4/CD8 ratio
also changed. Most interestingly, we found that the CD4/
CD45RC cells increased further compared with the total
GILs. This increase appears mainly to be the result of the
CD4/CD45RC cells rather than the total CD4 cells on
day 5 after transplantation. This change is specific for the
grafts because a similar change was found only in the
regional mediastinal lymph nodes and not in the mesenteric
lymph nodes, spleen, and peripheral blood. Thus the acute
lung graft rejection might be not only due to the increase in
number of lymphocytes but also due to the shift of lympho-
cyte subpopulations.
Fournier and colleagues22 investigated immunocyte ex-
pression in the respiratory tract in patients undergoing lung
transplantation using antibodies against CD4, CD8,
CD45RO, and HLADR. Immunohistologic findings indi-
cated that the immunocyte profile in the respiratory tract did
not reflect the process of acute rejection.22 In that study the
labeled immunocyte count was even less in the patients
undergoing lung transplantation than that in nonsmoking
control subjects. This seems to be attributable to the large
number of patients who exhibited minor acute rejection
rated as grade 1 because of the administration of immuno-
suppressants. Ibrahim and coworkers have previously
shown an increased expression of CD45RO cells during
human liver,16 heart,13 and kidney23 allograft rejection. Thus
the switch from CD45high to CD45low subtypes could be a
common phenomenon in acute rejection of allografts.
Importantly, we found that the expression of CD4/
CD45RC cells in BALF was also increased. The propor-
tion of CD4/CD45RC cells to CD4 lymphocytes in
BALF showed a significant increase from 60% on day 1 to
about 96% on days 3 and 5 (Figure 5, B). The increase of
CD4/CD45RC cells to CD4 cells in the grafts was
relatively smaller and late (from 57% on day 1 to 63% on
day 3 and 86% on day 5; Figure 3, B). Increased expression
of this subset of CD4 cells from BALF therefore might be
an early marker to detect acute lung graft rejection. The
existence of bronchus-associated lymphoid tissue in the
central bronchus might contribute to the earlier increase in
CD4/CD45RC cells in the BALF. After lung transplan-
tation, recipient lymphocytes might infiltrate to the bron-
chus-associated lymphoid tissue of the grafts in a relatively
early phase, and recipient and donor lymphocytes might
interact in these tissues.
The CD45R molecules are key molecules on lymphoid
cell surfaces. The relationship between the expression of
CD45RC on CD4 T cells and their functions are still not
clear. CD4/CD45RC T cells are associated with resting
cells, whereas CD4/CD45RC T cells are associated with
cells activated by the contact with previous antigens. It has
been shown that T cells stimulated in vitro lose CD45Rhigh
molecules and thus synthesize CD45Rlow molecules.24-27
The increase of CD4/CD45RC cells in the allografted
lung might be a result of the stimulation of lymphocytes by
alloantigens. On transplantation of skin allografts, CD4/
CD45RC T cells produce a larger amount of IL-2.28 Others
have found that CD4/CD45RC T cells help B cells to
produce a larger amount of IL-4.29,30 Therefore CD4/
CD45RC cells and CD4/CD45RC cells might corre-
spond to TH1-like and TH2-like subsets, respectively.31
However, the relationship between the CD45RC phenotype
and TH1-like/TH2-like dichotomy is still unclear.32,33 Inter-
estingly, it has been shown that CD45RB mAb could pre-
vent and reverse renal allograft rejection in mice34 and
could prolong xenograft survival in rat-to-mouse kidney and
heart transplantation.35 Thus the role of CD45R molecules
in allograft rejection and tolerance is still controversial and
merits further investigation.
Nevertheless, our results suggest that the increase in
CD4/CD45RC cells in allograft lung transplants might
be a marker of acute rejection of lung grafts, which can be
examined by means of bronchoalveolar lavage. However,
because we did not use immunosuppressants in this animal
model, the expression of this subtype of lymphocytes needs
to be further studied in the clinical setting.
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